Henry Schein (WBO:HSIC) ROCE % : 8.79% (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Henry Schein ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Henry Schein's annualized ROCE % for the quarter that ended in Dec. 2024 was 8.79%.

Henry Schein ROCE % Historical Data

The historical data trend for Henry Schein's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henry Schein ROCE % Chart

Henry Schein Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

9.76

15.22

12.42

8.70

8.59

Henry Schein Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															2.18	8.01	8.50	8.30	8.79

Henry Schein ROCE % Calculation

Henry Schein's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	615.02	/	( ( (9695.441 - 2460.311)	+	(9758.19 - 2676.865) )	/ 2 )
	=	615.02	/	( (7235.13	+	7081.325)	/ 2 )
	=	615.02	/	7158.2275
	=	8.59 %

Henry Schein's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	615.02	/	( ( (9555.105 - 2639.029)	+	(9758.19 - 2676.865) )	/ 2 )
	=	615.02	/	( ( 6916.076	+	7081.325 )	/ 2 )
	=	615.02	/	6998.7005
	=	8.79 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Henry Schein (WBO:HSIC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Henry Schein ROCE % Related Terms

Thank you for viewing the detailed overview of Henry Schein's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Henry Schein Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Henry Schein Inc (WBO:HSIC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

HSIC:USA 0L3C:UK HS2:Germany HS2:Germany

Address

135 Duryea Road, Melville, NY, USA, 11747

Website

https://www.henryschein.com

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.